Delivery Order SPE2DB22D2005-SPE2DB25FJSM2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,620.35 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on August 21, 2025, with a completion date of August 22, 2025. This delivery order, issued under a firm fixed-price contract with no set-aside designation, represents a competitively awarded procurement through open competition. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Jardiance 25 mg tablets in quantities of 90 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $94,228.99 and is scheduled for completion by August 12, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract type. The order, valued at $4,520.58, is scheduled for completion by July 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designations, reflecting AmerisourceBergen's established capability to...
- The Defense Logistics Agency awarded a delivery order valued at $55,053.97 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $14,137.08. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for ultimate completion on July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a medication...
- The Defense Logistics Agency awarded a delivery order valued at $11,275.03 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,908.03 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets in a 90-count package. This firm fixed-price delivery order, issued on July 28, 2025, is expected to be completed by July 29, 2025. The award represents a non-competitive set-aside contract executed through AmerisourceBergen's existing indefinite delivery vehicle with DLA Troop Support Medical. The product will be delivered to the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 25 mg tablets in a quantity of 90 units, with a ceiling value of $8,606.87. This competitively awarded delivery order utilizes firm fixed pricing and is scheduled for completion by August 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $1,530.68. This competitively awarded, firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity, with a contract ceiling value of $11,538.19. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting federal...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJSM2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $34,808.96 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Jardiance 25 mg tablets in a 90-count quantity. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor vehicle running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. Jardiance, a diabetes management medication, represents part of the company's extensive portfolio of prescription pharmaceuticals supplied to the Defense Health Agency and other federal healthcare customers. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and critical vendor for federal medical procurement, continues to demonstrate its capability to fulfill federal supply requirements across diverse therapeutic domains through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.8k | 8/25/25 |